Unaudited Condensed Interim Consolidated Statements of Cash Flows - USD ($)	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
Cash flows from Operating Activities
Net Loss	$ (10,105,914)	$ (7,239,000)
Adjustments to Reconcile Net Loss to Net Cash Used in Operating Activities
Stock based compensation	616,660	559,980
Bad debt (recovery) expense	(59,839)	94,714
Change in fair market value of warrant liability	(2,124)	(46,521)
Change in fair market value of contingent consideration		240,000
Gain on settlement of contingent consideration	0	(1,700,000)
Loss on impairment of goodwill and intangible assets	0	1,138,203
Amortization of right-of-use asset	647,358	834,889
Depreciation and amortization	2,187,321	1,484,968
Amortization of debt discount	617,664	53,646
Changes in operating assets and liabilities, net of effects of acquisitions:
Accounts receivable	(2,822,579)	(103,343)
Cost and estimated earnings excess of billings	(1,042,657)	(234,869)
Inventory	1,948,852	(2,612,773)
Vendor deposits	(724,845)	697,558
Prepaid expenses and other current assets	(146,197)	(161,797)
Accounts payable and accrued expenses	3,112,862	582,297
Other assets	(253,681)
Billings in excess of costs and earnings on uncompleted contracts	0	(1,254,496)
Deferred revenue	(915,205)	1,151,496
Due to landlord	(279,515)	(138,724)
Operating lease payments	(621,396)	(819,828)
Net Cash Used in Operating Activities	(7,843,235)	(7,473,600)
Cash Flows From Investing Activities
Cash paid for patent costs	(66,023)	(682)
Purchase of machinery and equipment	(248,319)	(46,196)
Acquisitions, net of cash acquired (Note 2)	(4,115,709)	(10)
Payments on notes payable	(166,262)	(41,730)
Net Cash Used in Investing Activities	(4,596,313)	(88,618)
Cash Flows From Financing Activities
Payments on financing leases	(30,994)	(5,269)
Shares repurchased	0	(149,686)
Dividends to preferred shareholders	(769,481)	(1,086,750)
Proceeds from equity raises, net	6,630,799	1,092,000
Proceeds from note payable, net	5,421,650	0
Net Cash Provided by (Used in) Financing Activities	11,251,974	(149,705)
Net Decrease in Cash and equivalents	(1,187,574)	(7,711,923)
Cash and cash equivalents at January 1,	2,734,485	8,768,156
Cash and cash equivalents at September 30,	1,546,911	1,056,233
Cash paid during the year for:
Interest	642,877	101,365
Supplemental Non-Cash Disclosures of Investing and Financing Activities
Conversion of debt into common stock	767,500	0
Recognition of right of use asset and corresponding lease liability	563,315	1,380,658
Accrued dividends	424,750
Issuance of note payable for payment of prepaid expense	$ 279,347	$ 318,833